Collaborative Community against Coronovirus CIC (CCC CIC)

Not-for-profit preparing communities for viral epidemics.

covid-19 swab testing

A not-for-profit Community Interest Company (CIC) collaborative dedicated to ensuring that the worldwide community is better prepared for the epidemics caused by viruses.

They propose a new approach to emerging viruses, developing inhibitors of the viral RNA polymerase complex of coronaviruses, including COVID-19, to prevent researchers from beginning from a 'zero base' to combat a virus.

3C is led by a group of experts with backgrounds in antiviral drug discovery, in both pharma and biotech.

The CCC CIC journey so far: 

  • 2020: community interest company founded

Team

Dr Edward Littler

Dr. Edward Littler

Founder and CEO

Dr. Littler has 34 years of experience in anti-viral and microbial research, with additional experience in large pharma and biotech.

Ana Lemmo Charnalia

Senior Business Manager

Ana managed the Health Social Innovators’ Programme at UCL Ventures, a partnership with THT Social Investments to support early-stage health ventures which received backing from Janssen Healthcare Innovation and the Cabinet Office’s Social Incubator Fund.

Her current responsibilities within UCL Ventures include commercialising research from the Social Sciences, Humanities and the Arts (SHAPE) as well as developing social venture opportunities (for profit, for purpose businesses) arising from UCL’s research base.

Prior to joining UCL Ventures, Ana provided funding and support to social entrepreneurs at UnLtd, the Foundation for Social Entrepreneurs in the UK.

She holds an MBA from Oxford University.